Spryker Earns Full Medal Count in Paradigm B2B Enterprise Combine

BERLIN and NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) — Spryker, the leading composable commerce platform for global enterprises, announced its performance in the 2025 Paradigm B2B Enterprise Combine for Digital Commerce Solutions for B2B analyst report. Spryker medaled in all 12 of the categories of the evaluation, including six gold medals, four silver medals, […]

Spryker Earns Full Medal Count in Paradigm B2B Enterprise Combine

Spryker Earns Full Medal Count in Paradigm B2B Enterprise Combine This analyst recognition further solidifies Spryker as a leading commerce solution for enterprises to future-proof their business amidst market volatility GlobeNewswire July 18, 2025 BERLIN and NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) — Spryker, the leading composable commerce platform for global enterprises, announced its

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, ENZB, STRM on Behalf of Shareholders

(NYSE:OLO),(NASDAQ:STRM),(Other OTC:ENZB), NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Olo Inc. (NYSE: OLO)'s sale to Thoma Bravo for $10.25 per share in cash. If

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, ENZB, STRM on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, ENZB, STRM on Behalf of Shareholders GlobeNewswire July 18, 2025 NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Royalty Pharma Declares Third Quarter 2025 Dividend

(NASDAQ:RPRX), NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on September 10, 2025, to shareholders of record at the close

Royalty Pharma Declares Third Quarter 2025 Dividend

Royalty Pharma Declares Third Quarter 2025 Dividend GlobeNewswire July 18, 2025 NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on

Air Products Declares Quarterly Dividend

The Board of Directors of Air Products (NYSE:APD) today declared a quarterly dividend of $1.79 per share of common stock. The dividend is payable on November 10, 2025 toshareholders of record at the close of business on October 1, 2025. About Air Products Air Products (NYSE:APD) is a world-leading industrial gases company in operation for

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

(NASDAQ:SRPT), LOS ANGELES, July 18, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ: SRPT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire July 18, 2025 LOS ANGELES, July 18, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ:

Bitcoin Solaris Presale Surges Past $6.6M as Altcoin Season Heats Up, Launch Target Set at $20

TALLINN, Estonia, July 18, 2025 (GLOBE NEWSWIRE) — As altcoin season accelerates, Bitcoin Solaris (BTC-S) is rapidly emerging as a standout project, attracting over 14,200 users and surpassing $6.6 million raised during its presale. With its official launch scheduled for July 31, 2025, Bitcoin Solaris has locked in a target launch price of $20, drawing

Scroll to Top